EZLife Bio featured in GenomeWeb

20 November 2018

EZLife Bio’s recent research initiative with the UCLA School of Dentistry was recently featured on genomeweb. Read about how our new initiative with the UCLA School of Dentistry and UCLA School of Medicine can help transform lung cancer screening.

EZLife Bio 2018 Trade Show Wrapup

13 November 2018

EZLife Bio recently wrapped up its trade shows for the year. We covered a lot of different tradeshows. Here are some fun highlights from all our recent trade shows. EZLife Bio’s Founder and CEO, Dr. Wei Liao, explaining the EFIRM platform and technology to customers at the 256th National Meeting...

EFIRM for Early Stage Cancer Detection: Journal of Molecular Diagnostics Publication

15 October 2018

EZLife Bio, in collaboration with the UCLA School of Dentistry recently published a groundbreaking study on using EFIRM for detection of early stage plasma samples. Using a clinical cohort from National Cheng Kung University Hospital (成大醫院),EFIRM was able to achieve unprecedenented sensitivity and specificity on detecting EGFR mutations in a...

National Cancer Institute Funds U01 Consortium between UCLA and EZLife Bio

01 October 2018

NIH-NCI has recently awarded 5 million to UCLA in order to study EFIRM early stage lung cancer screening! This news was featured on the UCLA Newsroom This U01 is an academic industrial partnership between UCLA and EZLife Bio. EZLife Bio will provide critical support on all instrumentation development and automation...